Christopher Pederson - Feb 11, 2022 Form 4 Insider Report for AVIENT CORP (AVNT)

Signature
/s/ Lisa K. Kunkle, Power of Attorney For: Christopher Pederson
Stock symbol
AVNT
Transactions as of
Feb 11, 2022
Transactions value $
-$93,383
Form type
4
Date filed
2/15/2022, 04:02 PM
Next filing
Jan 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNT Common Stock Options Exercise +5.35K +1357.87% 5.74K Feb 11, 2022 Direct F1, F2
transaction AVNT Common Stock Tax liability -$93.4K -1.77K -30.88% $52.64 3.97K Feb 11, 2022 Direct F3
holding AVNT Common Stock 3.33K Feb 11, 2022 Savings Plan Trust F4
holding AVNT Common Stock 2.15K Feb 11, 2022 Supplemental Plan F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVNT Restricted Stock Units Options Exercise -5.35K -100% 0 Feb 11, 2022 Common Stock 5.35K Direct F1
transaction AVNT Restricted Stock Units Award $0 +4.45K $0.00 4.45K Feb 14, 2022 Common Stock 4.45K Direct F1
transaction AVNT Stock Appreciation Rights Award $0 +15.7K $0.00 15.7K Feb 14, 2022 Common Stock 15.7K $52.64 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Avient common stock.
F2 Includes dividend equivalents earned with respect to the vested restricted stock units.
F3 Represents shares of Avient common stock that were withheld solely to satisfy the tax withholding obligation applicable to the vesting of restricted stock units on February 11, 2022.
F4 The information in this report is based on a plan statement as of February 11, 2022.
F5 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $52.64 per share and no more than one-third of the grant can vest per year during the first three years.